These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9593678

  • 1. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.
    Ji ZS, Pitas RE, Mahley RW.
    J Biol Chem; 1998 May 29; 273(22):13452-60. PubMed ID: 9593678
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
    Ji ZS, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley RW.
    J Biol Chem; 1993 May 15; 268(14):10160-7. PubMed ID: 7683668
    [Abstract] [Full Text] [Related]

  • 4. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS, Fazio S, Mahley RW.
    J Biol Chem; 1994 May 06; 269(18):13421-8. PubMed ID: 8175773
    [Abstract] [Full Text] [Related]

  • 5. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
    Ji ZS, Fazio S, Lee YL, Mahley RW.
    J Biol Chem; 1994 Jan 28; 269(4):2764-72. PubMed ID: 8300609
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan.
    Fu Y, Zhao J, Atagi Y, Nielsen HM, Liu CC, Zheng H, Shinohara M, Kanekiyo T, Bu G.
    Mol Neurodegener; 2016 May 05; 11(1):37. PubMed ID: 27151330
    [Abstract] [Full Text] [Related]

  • 7. Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans.
    Hara M, Matsushima T, Satoh H, Iso-o N, Noto H, Togo M, Kimura S, Hashimoto Y, Tsukamoto K.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):269-74. PubMed ID: 12588770
    [Abstract] [Full Text] [Related]

  • 8. Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity.
    de Beer F, Hendriks WL, van Vark LC, Kamerling SW, van Dijk KW, Hofker MH, Smelt AH, Havekes LM.
    Arterioscler Thromb Vasc Biol; 1999 Mar 01; 19(3):633-7. PubMed ID: 10073967
    [Abstract] [Full Text] [Related]

  • 9. Heparan sulfate proteoglycans mediate internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages.
    Seo T, St Clair RW.
    J Lipid Res; 1997 Apr 01; 38(4):765-79. PubMed ID: 9144091
    [Abstract] [Full Text] [Related]

  • 10. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.
    Ji ZS, Sanan DA, Mahley RW.
    J Lipid Res; 1995 Mar 01; 36(3):583-92. PubMed ID: 7539827
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cells: role of heparan sulfate proteoglycans and apolipoprotein E.
    Newman P, Bonello F, Wierzbicki AS, Lumb P, Savidge GF, Shearer MJ.
    J Bone Miner Res; 2002 Mar 01; 17(3):426-33. PubMed ID: 11874234
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.
    Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE.
    Science; 1994 May 06; 264(5160):850-2. PubMed ID: 8171342
    [Abstract] [Full Text] [Related]

  • 14. Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins.
    Ji ZS, Dichek HL, Miranda RD, Mahley RW.
    J Biol Chem; 1997 Dec 12; 272(50):31285-92. PubMed ID: 9395455
    [Abstract] [Full Text] [Related]

  • 15. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture.
    Ji ZS, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW.
    J Biol Chem; 1994 May 06; 269(18):13429-36. PubMed ID: 8175774
    [Abstract] [Full Text] [Related]

  • 16. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S, Abraham CR, Zannis VI.
    Biochemistry; 1997 Aug 26; 36(34):10571-80. PubMed ID: 9265639
    [Abstract] [Full Text] [Related]

  • 17. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD.
    Pathology; 2019 Feb 26; 51(2):165-176. PubMed ID: 30598326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
    Tacken PJ, Beer FD, Vark LC, Havekes LM, Hofker MH, Willems Van Dijk K.
    Biochem J; 2000 Apr 15; 347(Pt 2):357-61. PubMed ID: 10749663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.